Research & Development
U.S. IVD market reaches $53 billion
According to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.
March 22, 2023
Gestational diabetes rise linked to screening practices
Although gestational diabetes is reportedly on the rise, a study finds that changes in screening practices may explain much of the increase.
March 20, 2023
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
GlycoMark prediabetes biomarker test validated in Swiss study
Glycomark, which has been cleared by the FDA and has been granted the CE Mark, is a nonfasting blood test that measures the biomarker 1,5-anhydroglucitol to identify individuals at greatest risk of progressing from prediabetes to type 2 diabetes.
February 22, 2023
Cedars Sinai researchers find that COVID-19 infection increases diabetes risk
In a study, the researchers found that people who have had COVID-19 are at increased risk for new-onset diabetes type 2 diabetes; vaccination prior to infection may reduce this risk.
February 14, 2023
MicroRNAs strongly associated with type 2 diabetes in study
The results of the large-scale genetic analysis, published Thursday in the Proceedings of the National Academy of the Sciences, are expected to inform future studies on the early detection and treatment of diabetes.
February 10, 2023
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Quest Diagnostics offers suite of services for transplant patients and living donors
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
Consortium nabs $10M European grant to develop drug response tests for CKD
The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.
January 26, 2023
EMR screening program identifies prevalent undiagnosed diabetes
A published study underscored long-existing disparities in type 2 diabetes diagnosis and treatment by race, ethnicity, and socioeconomic factors. Such disparities increased during the COVID-19 pandemic.
January 27, 2023
Klick Applied Sciences showcases study data demonstrating AI method for predicting diabetes
Scientists from Klick Applied Sciences are developing a method of predicting diabetes by combining continuous glucose monitor technology with machine-learning models.
December 2, 2022
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
HbA1c screening in adults between 40 and 70 years of age can reduce the time to diabetes diagnosis by a median of 2.2 years compared with routine clinical care, the authors found.
November 22, 2022
LumiraDx announces commercial expansion of HbA1c test
The LumiraDx HbA1c test is an actively controlled microfluidic assay that provides results in seven minutes in a near-patient setting.
November 14, 2022
COVID-19 escalates risk for type 1 diabetes: Norway study
The study, conducted by the Norwegian Institute of Public Health (NIPH) in Oslo, Norway, used national health registers to examine new-onset type 1 diabetes diagnoses in all youngsters under 18 in Norway (more than 1.2 million individuals) over the course of two years.
September 26, 2022
Page 1 of 6